Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) has a beta value of 2.11 and has seen 0.45 million shares traded in the recent trading session. The company, currently valued at $55.24M, closed the recent trade at $9.88 per share which meant it lost -$1.07 on the day or -9.77% during that session. The TNXP stock price is -12531.58% off its 52-week high price of $1248.00 and -9.51% below the 52-week low of $10.82.
The consensus among analysts is that Tonix Pharmaceuticals Holding Corp (TNXP) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 1 out of 5 have rated it as a Hold, with 4 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -768.
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) trade information
Sporting -9.77% in the red today, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the TNXP stock price touched $9.88 or saw a rise of 20.45%. Year-to-date, Tonix Pharmaceuticals Holding Corp shares have moved -70.04%, while the 5-day performance has seen it change -17.25%. Over the past 30 days, the shares of Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) have changed -58.05%.
Tonix Pharmaceuticals Holding Corp (TNXP) estimates and forecasts
The company’s shares have lost -77.92% over the past 6 months. Revenue growth from the last financial year stood is estimated to be 64.78%.
2 analysts offering their estimates for the company have set an average revenue estimate of 3.2M for the current quarter. 1 have an estimated revenue figure of 4.2M for the next ending quarter. Year-ago sales stood 3.78M and 2.48M respectively for this quarter and the next, and analysts expect sales will shrink by -15.32% for the current quarter and 64.78% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 79.31% over the past 5 years. Earnings growth for 2025 is a modest 95.88% while over the next 5 years, the company’s earnings are expected to increase by 78.59%.
TNXP Dividends
Tonix Pharmaceuticals Holding Corp is expected to release its next earnings report in March this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP)’s Major holders
Also the top two Mutual Funds that are holding company’s shares are Fidelity Extended Market Index Fund and Vanguard Extended Market Index Fund. As of Nov 30, 2024, the former fund manager holds about 0.02% shares in the company for having 1.12 shares of worth $11048.0 while later fund manager owns 73.0 shares of worth $717.0 as of Sep 30, 2024, which makes it owner of about 0.00% of company’s outstanding stock.
